Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Antimicrob Agents Chemother ; 56(4): 2119-21, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22290962

RESUMEN

During a ß-lactam resistance surveillance study, 12 IMP-18-positive Pseudomonas aeruginosa isolates belonging to 9 different pulsed-field gel electrophoresis groups were identified. In nine isolates, a class I integron with a novel gene array was identified that contained bla(IMP-18) and bla(OXA-224), while in two isolates the class I integron contained bla(IMP-18) and bla(OXA-2) but in a new arrangement. Our findings show the dissemination of two novel class I integrons in P. aeruginosa from different regions of Puerto Rico.


Asunto(s)
Integrones/genética , Infecciones por Pseudomonas/microbiología , Pseudomonas aeruginosa/genética , beta-Lactamasas/genética , Adulto , Anciano , Anciano de 80 o más Años , Electroforesis en Gel de Campo Pulsado , Femenino , Humanos , Lactante , Masculino , Análisis por Micromatrices , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Pseudomonas aeruginosa/efectos de los fármacos , Puerto Rico
2.
Mar Pollut Bull ; 58(1): 45-54, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18952244

RESUMEN

Human fecal contamination of coral reefs is a major cause of concern. Conventional methods used to monitor microbial water quality cannot be used to discriminate between different fecal pollution sources. Fecal coliforms, enterococci, and human-specific Bacteroides (HF183, HF134), general Bacteroides-Prevotella (GB32), and Clostridium coccoides group (CP) 16S rDNA PCR assays were used to test for the presence of non-point source fecal contamination across the southwestern Puerto Rico shelf. Inshore waters were highly turbid, consistently receiving fecal pollution from variable sources, and showing the highest frequency of positive molecular marker signals. Signals were also detected at offshore waters in compliance with existing microbiological quality regulations. Phylogenetic analysis showed that most isolates were of human fecal origin. The geographic extent of non-point source fecal pollution was large and impacted extensive coral reef systems. This could have deleterious long-term impacts on public health, local fisheries and in tourism potential if not adequately addressed.


Asunto(s)
Antozoos/microbiología , Microbiología Ambiental , Monitoreo del Ambiente/métodos , Heces/microbiología , Reacción en Cadena de la Polimerasa/métodos , Contaminantes del Agua/análisis , Animales , Antozoos/fisiología , Bacteroides/aislamiento & purificación , Bacteroides/fisiología , Biomarcadores , Recuento de Colonia Microbiana , Enterococcus/aislamiento & purificación , Enterococcus/fisiología , Escherichia coli/aislamiento & purificación , Escherichia coli/fisiología , Humanos , Océanos y Mares , Filogenia , Puerto Rico , Análisis de Regresión , Agua de Mar/química
3.
P. R. health sci. j ; 24(1): 41-44, mar. 2005.
Artículo en Inglés | LILACS | ID: lil-406521

RESUMEN

The development of diarrhea in hospitalized patients is a frequently encountered clinical problem, which may be due to infectious or non-infectious causes. The purpose of this study was to identify which common community enteric pathogens, if any, are responsible for diarrheal episodes in hospitalized patients. Stool samples from 76 consecutive, hospitalized patients were analyzed utilizing routine bacterial cultures, smears for identification of ova and parasites and Enzyme-Link Immunoadsorbent Assay (ELISA) for enteric bacteria, parasites and viruses. The results obtained demonstrated that the usual community enteric pathogens were not identified as a major cause of nosocomial diarrhea. In hospital-acquired diarrhea, Clostridium difficile toxins assay was the only clinically significant test in the evaluation of these patients. As a result of this study a guideline for the management of this condition in hospitalized patients is presented.


Asunto(s)
Humanos , Masculino , Femenino , Recién Nacido , Lactante , Preescolar , Niño , Adolescente , Adulto , Persona de Mediana Edad , Diarrea/microbiología , Gastroenteritis/microbiología , Diarrea/epidemiología , Gastroenteritis/epidemiología , Puerto Rico/epidemiología
4.
Med. intensiva (Madr., Ed. impr.) ; 28(8): 425-427, nov. 2004. ilus
Artículo en Es | IBECS | ID: ibc-35457

RESUMEN

Presentamos el caso de un paciente que precisó la administración de heparina no fraccionada para una terapia de reemplazo renal por una insuficiencia renal aguda anúrica, y se objetivó un descenso del recuento plaquetario mayor del 50 por ciento al séptimo día. La prueba de ELISA detectó los anticuerpos formados contra el complejo heparina/factor4 plaquetario y confirmó que se trataba de una trombocitopenia de origen inmune causada por la heparina. La actitud principal fue la supresión de cualquier exposición a la heparina y se inició un tratamiento con fármacos anticoagulantes alternativos para prevenir la elevada frecuencia de eventos trombóticos asociados a esta entidad clínica. El resultado fue una elevación progresiva del recuento plaquetario durante la semana siguiente a la suspensión de la heparina hasta su normalización y la ausencia de complicaciones tromboembólicas hasta el momento del alta hospitalaria (AU)


Asunto(s)
Anciano , Masculino , Humanos , Heparina/efectos adversos , Heparina , Heparina/uso terapéutico , Púrpura Trombocitopénica Idiopática , Terapia de Reemplazo Renal/métodos , Anticoagulantes/administración & dosificación , Anticoagulantes/uso terapéutico , Hemofiltración/métodos , Hemofiltración , Recuento de Plaquetas/métodos , Warfarina , Warfarina/efectos adversos , Ensayo de Inmunoadsorción Enzimática/métodos , Insuficiencia Renal/complicaciones , Insuficiencia Renal/diagnóstico , Colesteatoma/complicaciones , Trombina/análisis , Proteína C/análisis
5.
P. R. health sci. j ; 22(3): 265-271, Sept. 2003.
Artículo en Inglés | LILACS | ID: lil-355997

RESUMEN

Few studies have been performed in Puerto Rico concerning the antimicrobial resistance pattern of clinically significant Gram-negative bacilli. The antimicrobial resistance patterns of 5,590 Gram-negative bacteria obtained from three Community-Private Hospitals (CPH) and three University-Affiliated Hospitals (UAH) were evaluated utilizing the institutions' antimicrobial susceptibility reports for the year 2000. The objectives of this study were: to retrospectively evaluate the reported in vitro resistance of clinical isolates of E. coli, K. pneumoniae, E. cloacae, S. marcescens, P. aeruginosa and A. baumannii to selected standard antibiotics and to compare the antimicrobial resistance patterns between Community-Private (CPH) and University Affiliated hospitals (UAH). E. coli was the most common Gram-negative enteric bacilli in both CPH and UAH. In UAH, E. coli demonstrated a statistically significant higher resistance to the selected beta lactams and amikacin antibiotics but not to ciprofloxacin or gentamicin. For K. pneumoniae, the antimicrobial resistant pattern showed that UAH isolates were significantly more resistant to the tested antibiotics with the exception of ceftriaxone. In CPH, E. cloacae isolates were significantly more resistant to piperacillin-tazobactam, ciprofloxacin and gentamicin, while in UAH this organism was more resistant to amikacin. In UAH, S. marcescens isolates demonstrated a statistically significant higher resistance to all tested antibiotics with the exception of imipenem, which was similar in both hospitals group. Pseudomonas aeruginosa demonstrated a statistically significant higher resistance in UAH to all selected antibiotics with the exception of ciprofloxacin and gentamicin, which was similar in both hospitals group. Acinetobacter baumannii was the most resistant organisms in both hospitals group. UAH isolates were significantly more resistant than CPH isolates for all tested antibiotics. When compare with other large-scale antimicrobial resistance studies, the present study results suggest an apparent higher resistance in the Puerto Rican isolates. The high numbers of antimicrobial resistant Gram-negative bacilli in our study strongly suggest multiple mechanisms of antimicrobial resistance including the presence of extended spectrum and chromosomally derepressed beta-lactamases.


Asunto(s)
Bacterias Gramnegativas/efectos de los fármacos , Hospitales Privados/estadística & datos numéricos , Hospitales Universitarios/estadística & datos numéricos , Hospitales Urbanos/estadística & datos numéricos , Infección Hospitalaria/microbiología , Infecciones por Bacterias Gramnegativas/microbiología , Resistencia a Medicamentos , Bacterias Gramnegativas/aislamiento & purificación , Infección Hospitalaria/epidemiología , Infecciones por Bacterias Gramnegativas/epidemiología , Puerto Rico/epidemiología , Estudios Retrospectivos , Población Urbana
6.
P. R. health sci. j ; 22(2): 131-136, June 2003.
Artículo en Inglés | LILACS | ID: lil-356191

RESUMEN

The antimicrobial resistance patterns of 2,462 selected Gram-positive cocci obtained from three Community-Private Hospitals (CPH) and three University-Affiliated Hospitals (UAH) were evaluated utilizing the institutions' antimicrobial susceptibility reports for the year 2000. The objectives of this study were: 1) to evaluate the in vitro resistance to selected standard antibiotics of Staphylococcus aureus, Enterococcus faecalis, Enterococcus faecium and Streptococcus pneumoniae clinical isolates, and 2) to compare the antimicrobial resistance patterns between community-private (CPH) and university-affiliated hospitals (UAH). Staphylococcus aureus was the most common Gram-positive isolated organism in CPH (63.3 per cent) followed by E. faecalis (31.0 per cent). In UAH, the most prevalent cocci were E. faecalis (51.7 per cent) followed by S. aureus (43.9 per cent). Enterococcus faecium represented 2.3 per cent and 4.4 per cent of CPH and UAH isolates, respectively. Streptococcus pneumoniae represented 3.4 per cent of the total Gram-positive isolates from CPH, no S. pneumoniae was reported in UAH. The antimicrobial susceptibility results showed that for Staphylococcus aureus there was a statistically significant higher resistance to methicillin and thrimethoprim sulfamethoxazole in UAH, while resistance to erythromycin was significantly higher in CPH. There was no difference in the resistance of S. aureus to other antimicrobial agents between hospitals groups. A statistically significant resistant to vancomycin was found between enterococcal isolates from UAH (43 per cent) and CPH (12.7 per cent). High-level aminoglycoside resistance (HLAR) was observed among UAH enterococcal isolates with E. faecium showing a higher resistance than E. faecalis, no data for HLAR in CPH could be obtained. For pneumococci 46 per cent of CPH isolates were resistant to penicillin. In summary, there are important differences in the prevalence and antimicrobial resistance between the Gram-positive bacteria isolated from community and teaching hospitals.


Asunto(s)
Humanos , Cocos Grampositivos/aislamiento & purificación , Hospitales Comunitarios/estadística & datos numéricos , Hospitales Universitarios/estadística & datos numéricos , Infecciones por Bacterias Grampositivas/microbiología , Farmacorresistencia Bacteriana Múltiple , Cocos Grampositivos/efectos de los fármacos , Infecciones por Bacterias Grampositivas/tratamiento farmacológico , Pruebas de Sensibilidad Microbiana , Puerto Rico/epidemiología
7.
Lupus ; 12(1): 52-7, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12587827

RESUMEN

The purpose of this study was to compare the long-term effectiveness among danazol, corticosteroids, cytotoxics, and dapsone in the treatment of hematological manifestations of systemic lupus erythematosus (SLE). Medical charts of all patients seen at the Rheumatic Disease Unit from January to December of 1998 were reviewed. Patient characteristics, disease and treatment information were collected. The main outcome measures were the cause of and time to discontinuation of drugs used to treat hematological manifestations of SLE resulting from all causes, mainly toxicity and inefficacy or both. Bivariate analysis including one-way ANOVA and chi2 tests were used to compare differences between means and proportions, respectively. Survival curves among the different drugs were evaluated using the Kaplan-Meier method. Multivariate analysis (Cox-regression) was used to adjust for potential confounders. After all medical records were reviewed 41 cases were eligible. Two cases had hemolytic anemia, 34 had thrombocytopenia, and five had both. These cases had received a total of 121 cycles of treatment at different times and they represent the study population (corticosteroids n = 37, danazol n = 51, citotoxic drugs n = 29, and dapsone n = 4). Crude rates of discontinuations due to any cause, toxicity and inefficacy werenot statistically significant among the drugs. However, the Kaplan-Meier curves showed statistically significant difference for discontinuations due to all causes as well as inefficacy. Prednisone and cytotoxic drugs had the lowest probability of continuation. In contrast, there were not statistically significant differences among the drugs with respect to first relapse. This is the first study examining the long-term termination rates of several drugs used to treat hematological manifestations of SLE. Using rates of discontinuation adjusted for time there were statistically significant differences among the drugs. Danazol had the highest probability of continuation.


Asunto(s)
Antiinflamatorios/administración & dosificación , Danazol/administración & dosificación , Antagonistas de Estrógenos/administración & dosificación , Lupus Eritematoso Sistémico/complicaciones , Prednisolona/administración & dosificación , Trombocitopenia/tratamiento farmacológico , Adulto , Anemia Hemolítica/tratamiento farmacológico , Anemia Hemolítica/etiología , Antiinflamatorios/efectos adversos , Antiinflamatorios no Esteroideos/administración & dosificación , Antiinflamatorios no Esteroideos/efectos adversos , Azatioprina/administración & dosificación , Azatioprina/efectos adversos , Ciclofosfamida/administración & dosificación , Ciclofosfamida/efectos adversos , Dapsona/administración & dosificación , Dapsona/efectos adversos , Antagonistas de Estrógenos/efectos adversos , Femenino , Humanos , Inmunosupresores/administración & dosificación , Inmunosupresores/efectos adversos , Masculino , Prednisolona/efectos adversos , Recurrencia , Trombocitopenia/etiología
8.
P. R. health sci. j ; 21(4): 343-347, Dec. 2002.
Artículo en Inglés | LILACS | ID: lil-356229

RESUMEN

The Gram-positive cocci (GPC), Staphylococcus aureus, Streptococcus pneumoniae, Enterococcus faecalis and Enterococcus faecium, have become important causes of community and nosocomial-acquired infections. The prevalence of multiple resistant isolates to standard antimicrobial drugs has significantly increased over the past decades. Few prospective studies have been performed in Puerto Rico (PR) concerning the GPC antimicrobial susceptibilities pattern. The purpose of this study was to evaluate the in vitro susceptibility of GPC clinical isolates from PR to selected standard antibiotics and to the new antimicrobial agents, linezolid (LZ), quinupristin/dalfopristin (Q/D) and gemifloxacin (GM). The in vitro susceptibility utilizing disk diffusion and Etest methods to selected antibiotics was determined for a total of 429 isolates obtained during a period of 5 months from the Puerto Rico Medical Center Bacteriology Laboratory. The distribution of GPC collected was as follows: 213 S. aureus isolates, 162 E. faecalis, 16 E. faecium and 38 S. pneumoniae. The results of the susceptibility test demonstrated: 1) that in S. aureus, 100 per cent of the isolates were susceptible to vancomycin (VAN), LZ and Q/D; 93 per cent to GM; and 61 per cent to methicillin/oxacillin; 2) in S. pneumoniae, 100 per cent were susceptible to LN and GM; 87 per cent to Q/D; and 53 per cent to penicillin; 3) in E. faecalis, 99 per cent were susceptible to ampicillin; 93 per cent to LZ; 79 per cent to GM; 78.6 per cent to VAN; and 0 per cent to Q/D. Sixty eight and 66 per cent of the E. faecalis isolates were susceptible to gentamicin and streptomycin respectively; and 4) in E. faecium, 100 per cent were susceptible to LZ; 94 per cent to Q/D; 69 per cent to GM; 37.5 per cent to VAN and 20 per cent to ampicillin. In E. faecium isolates, 50 per cent and 31 per cent were susceptible to gentamicin and streptomycin, respectively. Of the vancomycin resistant enterococci, 88.9 per cent and 21 per cent of E. faecium and faecalis showed VanA phenotypic resistance, respectively...


Asunto(s)
Humanos , Cocos Grampositivos/efectos de los fármacos , Pruebas de Sensibilidad Microbiana/métodos , Cocos Grampositivos/aislamiento & purificación , Estudios Prospectivos , Puerto Rico
9.
Women Health ; 31(2-3): 37-56, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11289685

RESUMEN

A content analysis was conducted to evaluate the description of postpartum mood disturbances in magazine articles that appeared during the years 1980-1998. Nineteen articles about postpartum depression and eight articles about "the baby blues" were identified and analyzed for their discussion of etiologies, symptoms, treatments, resources, and demographic assumptions about their readers. The results indicate a strong bias in favor of the medical model of postpartum affective disorders. The articles contained contradictory information about the definition, prevalence, onset, duration, symptoms, and treatment of postpartum disorders, and the authors generally assumed that their readers were heterosexual, married, and middle class. Although the purpose of the articles was to educate readers about an important topic in women's health, they failed to provide accurate information, and thus are not a sufficient resource for new mothers who are seeking to learn about psychosocial aspects of the postpartum period.


Asunto(s)
Depresión Posparto , Educación en Salud/normas , Servicios de Información/normas , Medios de Comunicación de Masas/normas , Publicaciones Periódicas como Asunto/normas , Bibliometría , Depresión Posparto/etiología , Depresión Posparto/patología , Depresión Posparto/prevención & control , Depresión Posparto/terapia , Femenino , Humanos , Medios de Comunicación de Masas/estadística & datos numéricos , Embarazo , Salud de la Mujer
10.
P R Health Sci J ; 12(4): 259-62, 1993 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-8140203

RESUMEN

A total of 49 endemic plants of Puerto Rico were evaluated for their toxicological and antibacterial activities. The toxicological analysis was conducted with brine shrimp (Artemia salina Leach) lethality bioassay and the antibacterial screening was carried out by means of the agar diffusion test. In the toxicological bioassay, six plant extracts showed LC-50 values below 200 g/ml., indicating the potential presence of bioactive compounds. In the antibacterial screening, over 80% of the plant extracts displayed activity against gram positive bacteria, whereas only 6% of the extracts inhibited the growth of the gram negative bacteria.


Asunto(s)
Extractos Vegetales/toxicidad , Animales , Artemia , Dosificación Letal Mediana , Pruebas de Sensibilidad Microbiana , Extractos Vegetales/uso terapéutico , Puerto Rico
11.
P R Health Sci J ; 11(3): 135-8, 1992 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-1475343

RESUMEN

Four bacteria-derived immunopotentiators were tested for their protective effect on a P-388 mouse lymphocytic leukemia model. The microbial test products were prepared from the following bacterial strains: ATCC 35983 Staphylococcus epidermidis isolated from a patient with IV catheter; ATCC 31874, a patented strain listed as Staphylococcus epidermidis isolated from the urine of a cancer patient; ATCC 25615 Staphylococcus hominis obtained from a child with lymphocytic leukemia, and ATCC 25614 Staphylococcus warneri, an isolate from a patient with adenocarcinoma of the breast. A limited degree of protection and prolongation in survival time was observed in the animal group treated with the bacterial strain ATCC 31874.


Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Leucemia P388/terapia , Staphylococcus epidermidis/crecimiento & desarrollo , Staphylococcus/crecimiento & desarrollo , Adyuvantes Inmunológicos/biosíntesis , Animales , Inmunoterapia/métodos , Leucemia P388/inmunología , Masculino , Ratones , Ratones Endogámicos , Staphylococcus/metabolismo , Staphylococcus epidermidis/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...